Premium
The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder
Author(s) -
Luzzago Stefano,
Palumbo Carlotta,
Rosiello Giuseppe,
Pecoraro Angela,
Deuker Marina,
Tian Zhe,
Shariat Shahrokh F.,
Saad Fred,
Cobelli Ottavio,
Karakiewicz Pierre I.
Publication year - 2019
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.25717
Subject(s) - medicine , cystectomy , chemotherapy , proportional hazards model , urology , metastatic urothelial carcinoma , hazard ratio , bladder cancer , propensity score matching , oncology , cohort , urinary bladder , surgery , cancer , urothelial carcinoma , confidence interval
Background To test the effect of radical cystectomy (RC) with chemotherapy vs only chemotherapy on overall mortality (OM) in metastatic urothelial carcinoma of the urinary bladder (mUCUB). Methods Within the Surveillance, Epidemiology, and End Results registry (2004–2016), we identified patients with mUCUB. Stratification was made according to treatment: RC with chemotherapy vs only chemotherapy. Kaplan‐Meier plots and multivariable Cox regression models were used before and after 1:1 propensity score (PS) matching and inverse probability of treatment weighting (IPTW). Results Of 2414 patients with mUCUB, 500 (21.0%) vs 1914 (79.0%) were treated with RC with chemotherapy vs only chemotherapy, respectively. In multivariable Cox regression models, RC with chemotherapy was associated with lower OM in the overall cohort (hazard ratio [HR], 0.5; P < .001), after 1:1 PS matching (HR, 0.5; P < .001), after IPTW (HR, 0.5; P < .001) and after accounting for number and location of metastases (HR, 0.5; P < .001). However, higher overall survival after RC with chemotherapy was only observed in patients with one metastatic site (21 vs 16 months; P = .001). Conclusion In contemporary patients with mUCUB, RC with chemotherapy is associated with lower OM rates, relative to chemotherapy alone, but only in patients with a single metastatic site. These individuals accounted for the vast majority of patients in whom an RC was performed, despite the presence of metastatic disease.